2024-2032 年按類型（處方藥、非處方藥）、藥物類別、給藥途徑、疼痛類型、應用和地區分類的鎮痛藥市場報告

2023年全球鎮痛藥市場規模達541億美元。展望未來， IMARC Group預計到2032年市場規模將達到772億美元，2024-2032年複合年成長率（CAGR）為3.9%。對非處方藥（OTC）的需求不斷增加、新型鎮痛藥和給藥方法的開發以及關節炎和偏頭痛等慢性疾病發病率的增加是推動市場發展的主要因素。

鎮痛藥是主要用於減輕疼痛和不適的物質或藥物。它的作用是針對神經系統來減少疼痛感，而不解決根本原因。它可分為非類固醇類抗發炎藥（NSAID）、鴉片類藥物和非鴉片類藥物。此外，非類固醇抗發炎藥（包括布洛芬和阿斯匹靈）可以透過減輕發炎來減輕疼痛。鴉片類藥物，如嗎啡和可待因，作用於中樞神經系統，提供更有效的止痛效果，可能具有成癮性。因此，包括對乙醯氨基酚在內的非鴉片類鎮痛藥越來越受歡迎，可以緩解疼痛，而不會產生鴉片類藥物的成癮風險。

疼痛相關疾病發生率的增加以及人們對疼痛管理重要性的認知不斷增強，推動了市場的發展。此外，癌症、糖尿病和心血管疾病等慢性疾病的流行，往往伴隨慢性疼痛症狀，需要使用止痛藥來緩解，進而影響市場成長。此外，醫療技術的進步導致更多的手術干預和術後疼痛管理，導致醫院和診所使用鎮痛藥，這是另一個主要的成長誘導因素。除此之外，不斷成長的老年人口容易患有關節炎和肌肉骨骼疾病等慢性疼痛，這正在加速產品需求。除此之外，久坐的生活方式、不良姿勢和壓力水平增加都會導致疼痛投訴增加，導致人們尋求非處方藥來緩解頭痛、背痛和肌肉酸痛，從而推動市場成長。

鎮痛藥市場趨勢/促進因素：

慢性疾病的發生率不斷上升

這個市場是由關節炎和偏頭痛等慢性疾病的流行所推動的。此外，不斷成長的老年人口更容易患關節炎、骨關節炎和類風濕性關節炎等慢性疾病，這些疾病的特徵通常是持續性關節疼痛和炎症，需要使用鎮痛藥來控制疼痛，這正在影響市場的成長。此外，糖尿病、心血管疾病和癌症等慢性疾病的發生率不斷上升，對止痛解決方案的需求不斷增加，這是另一個主要的成長誘導因素。許多這些疾病都與疼痛症狀或治療副作用有關，因此止痛藥成為治療和安寧療護策略的重要組成部分。此外，生活方式的改變導致慢性疾病、久坐生活方式、不良飲食習慣以及與慢性背痛、偏頭痛和纖維肌痛等疾病相關的高壓力水平激增，導致人們採用鎮痛藥來緩解不適和提高他們的生活品質，正在創造積極的市場前景。

新型鎮痛藥物及給藥方法的開發

近年來，市場取得了顯著進步，特別是在新藥和創新遞送方法的開發方面。這些進步對於重塑景觀至關重要。此外，製藥公司正在投資研發（R＆D），以開發新藥，以更有效地緩解疼痛，同時最大限度地減少副作用，從而影響市場成長。它們通常針對體內特定的疼痛途徑，提供更量身定做的疼痛管理方法。此外，遺傳學和藥物基因組學的進步使得個人化疼痛管理成為可能，醫療保健提供者在開藥時會考慮患者的基因組成，確保採取更量身定做和有效的治療方法，這是另一個主要的生長誘導因素。除此之外，幾種創新的給藥方法，包括經皮貼片、靜脈輸注和皮下注射，提供了鎮痛藥物的替代方法，可以提供受控、持續的疼痛緩解並提高患者的依從性，從而推動市場成長。

對非處方藥 (OTC) 的需求不斷增加

市場擴張歸因於場外交易（OTC）領域的成長。此外，消費者在管理自己的健康方面變得更加主動，並在解決頭痛、肌肉疼痛或輕傷等常見疾病時尋求便利和可及性，從而影響了市場的成長。此外，不斷成長的藥局和零售店正在擴大其非處方鎮痛產品，使這些產品更容易為消費者所接受，包括多個品牌和配方，滿足不同的止痛需求，這是另一個主要的成長誘導因素。除此之外，人們對非處方藥的安全性、有效性、正確使用和潛在副作用的認知不斷增強，建立了對這些產品的信任，從而加速了市場成長。除此之外，現代生活方式涉及繁忙的日程和壓力，導致頭痛和身體疼痛的情況增加，從而導致採用非處方鎮痛藥，其易於購買和使用成為尋求快速緩解日常疼痛的人們的首選不適。

目錄

第1章：前言

第 2 章：範圍與方法

• 研究目的
• 利害關係人
• 資料來源
  • 主要資源
  • 二手資料
• 市場預測
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第 3 章：執行摘要

第 4 章：簡介

• 概述
• 主要行業趨勢

第 5 章：全球鎮痛藥市場

• 市場概況
• 市場業績
• COVID-19 的影響
• 市場區隔：按類型
• 市場區隔：依藥品類別
• 市場區隔：依給藥途徑
• 市場區隔：按疼痛類型
• 市場區隔：按應用
• 市場區隔：按地區
• 市場預測

第 6 章：市場區隔：按類型

• 處方
  • 市場走向
  • 市場預測
• 櫃檯交易（OTC）
  • 市場走向
  • 市場預測

第 7 章：市場區隔：依藥物類別

• 鴉片類藥物
  • 市場走向
  • 市場預測
• 非類固醇抗發炎藥
  • 市場走向
  • 市場預測
• 其他
  • 市場走向
  • 市場預測

第 8 章：市場區隔：依管理途徑

• 口服
  • 市場走向
  • 市場預測
• 注射用
  • 市場走向
  • 市場預測
• 專題
  • 市場走向
  • 市場預測
• 經皮
  • 市場走向
  • 市場預測
• 直腸
  • 市場走向
  • 市場預測

第 9 章：市場區隔：按痛苦類型

• 肌肉骨骼
  • 市場走向
  • 市場預測
• 手術與創傷
  • 市場走向
  • 市場預測
• 癌症
  • 市場走向
  • 市場預測
• 神經病性
  • 市場走向
  • 市場預測
• 偏頭痛
  • 市場走向
  • 市場預測
• 產科
  • 市場走向
  • 市場預測
• 纖維肌痛
  • 市場走向
  • 市場預測
• 燒傷引起的疼痛
  • 市場走向
  • 市場預測
• 牙科/臉部護理
  • 市場走向
  • 市場預測
• 兒科
  • 市場走向
  • 市場預測
• 其他
  • 市場走向
  • 市場預測

第 10 章：市場區隔：按應用

• 內部的
  • 市場走向
  • 市場預測
• 外部的
  • 市場走向
  • 市場預測

第 11 章：市場區隔：按地區

• 北美洲
  • 市場走向
  • 市場預測
• 歐洲
  • 市場走向
  • 市場預測
• 亞太地區
  • 市場走向
  • 市場預測
• 中東和非洲
  • 市場走向
  • 市場預測
• 拉丁美洲
  • 市場走向
  • 市場預測

第 12 章：全球鎮痛藥產業：SWOT 分析

• 概述
• 優勢
• 弱點
• 機會
• 威脅

第 13 章：全球鎮痛藥產業：價值鏈分析

• 概述
• 研究與開發
• 原物料採購
• 製造業
• 行銷
• 分配
• 最終用途

第 14 章：全球鎮痛藥產業：波特五力分析

• 概述
• 買家的議價能力
• 供應商的議價能力
• 競爭程度
• 新進入者的威脅
• 替代品的威脅

第 15 章：全球鎮痛藥產業：價格分析

• 價格指標
• 價格結構
• 利潤分析

第16章：競爭格局

• 市場結構
• 關鍵參與者
• 關鍵參與者簡介
  • Bayer AG
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Reckitt Benckiser (RB) Group PLC
  • Endo Pharmaceuticals PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Sanofi SA

Abstract

The global analgesics market size reached US$ 54.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 77.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032. The escalating demand for over-the-counter (OTC) medicines, the development of novel analgesic drugs and delivery methods, and the growing incidences of chronic ailments such as arthritis, and migraines are some of the major factors propelling the market.

Analgesics are substances or medications primarily developed to alleviate pain and discomfort. It works by targeting the nervous system to reduce the perception of pain without addressing the underlying cause. It can be classified into non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and non-opioids. Additionally, NSAIDs, including ibuprofen and aspirin, reduce pain by mitigating inflammation. Opioids, such as morphine and codeine, act on the central nervous system to provide more potent pain relief, which can have addictive potential. As a result, the growing popularity of non-opioid analgesics, including acetaminophen, offers pain relief without the addictive risks of opioids.

The market is driven by increasing incidences of pain-related conditions and a growing awareness of the importance of pain management. In addition, the prevalence of chronic ailments, including cancer, diabetes, and cardiovascular diseases, often come with chronic pain as a symptom, requiring the use of analgesics for relief, thus influencing market growth. Moreover, advances in medical technology led to more surgical interventions and post-operative pain management, leading to the use of analgesics in hospitals and clinics, representing another major growth-inducing factor. Besides this, the growing geriatric population is prone to chronic pain conditions such as arthritis and musculoskeletal disorders, which is accelerating the product demand. Along with this, sedentary lifestyles, poor posture, and increased stress levels contribute to increasing pain complaints, resulting in individuals seeking over-the-counter medicines for relief from headaches, back pain, and muscle aches, propelling the market growth.

Analgesics Market Trends/Drivers:

The growing incidences of chronic ailments

The market is driven by the prevalence of chronic ailments such as arthritis, and migraines. In addition, the growing geriatric population is more susceptible to chronic health conditions such as arthritis, osteoarthritis, and rheumatoid arthritis which are often characterized by persistent joint pain and inflammation, requiring the use of analgesics for pain management, is influencing the market growth. Moreover, the rising incidence of chronic diseases including diabetes, cardiovascular disorders, and cancer are escalating the demand for pain relief solutions, representing another major growth-inducing factor. Many of these diseases are associated with painful symptoms or side effects of treatments, making analgesics an essential component of the management and palliative care strategies. Furthermore, lifestyle changes are contributing to the surge in chronic ailments, sedentary lifestyles, poor dietary habits, and high-stress levels linked to conditions such as chronic back pain, migraines, and fibromyalgia, resulting in the adoption of analgesics to alleviate their discomfort and enhance their quality of life, are creating a positive market outlook.

The development of novel analgesic drugs and delivery methods

The market has witnessed significant advancements in recent years, particularly in the development of novel drugs and innovative delivery methods. These advancements are essential in reshaping the landscape. In addition, pharmaceutical companies are investing in research and development (R&D) to create novel drugs developed to be more effective in providing pain relief while minimizing side effects, influencing market growth. They often target specific pain pathways in the body, offering a more tailored approach to pain management. Moreover, advances in genetics and pharmacogenomics allowed for personalized pain management., and healthcare providers consider a patient's genetic makeup when prescribing medicines, ensuring a more tailored and effective treatment approach, representing another major growth-inducing factor. Along with this, several innovative delivery methods, including transdermal patches, intravenous infusions, and subcutaneous injections offer alternative ways to administer analgesics that can provide controlled, sustained pain relief and improve patient compliance, propelling the market growth.

Escalating demand for over-the-counter (OTC) medicines

The market expansion is due to growing the over-the-counter (OTC) segment. In addition, consumers are becoming more proactive in managing their health and seek convenience and accessibility when it comes to addressing common ailments including headaches, muscle pain, or minor injuries, thus influencing the market growth. Moreover, the growing pharmacies and retail outlets are expanding their OTC analgesic offerings, making these products more accessible to consumers including several brands and formulations, catering to different pain relief needs, representing another major growth-inducing factor. Besides this, the growing awareness of OTC drugs' safety, effectiveness, proper use, and potential side effects, has built trust in these products, thus accelerating the market growth. Along with this, modern lifestyles involve hectic schedules and stress, leading to increased instances of headaches and body aches resulting in the adoption of OTC analgesics, with their ease of purchase and use becoming a go-to choice for individuals seeking quick relief from these everyday discomforts.

Analgesics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on type, drug class, route of administration, pain type and application.

Breakup by Type:

Prescription

Over the counter (OTC)

Prescription analgesics represent the most popular type

The report has provided a detailed breakup and analysis of the market based on the type. This includes prescription, over-the-counter (OTC). According to the report, prescriptions accounted for the largest market share.

The prescription analgesics market is typically dispensed under the supervision of a healthcare professional. It offers a higher level of efficacy and potency compared to its over-the-counter (OTC) counterparts which are often recommended for patients experiencing severe or chronic pain. This effectiveness makes them a preferred choice for healthcare providers when managing pain associated with conditions including post-surgical recovery, cancer, and advanced musculoskeletal disorders.

Moreover, it includes numerous drug classes, allowing healthcare practitioners to tailor treatment to the specific needs of individual patients, thus representing another major growth-inducing factor. It includes opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and adjuvant medications, each addressing different types and levels of pain.

Besides this, the rising importance of proper dosage and monitoring by healthcare professionals to minimize the risk of misuse, addiction, and adverse side effects, particularly concerning opioids is accelerating the market growth.

Additionally, the growing geriatric population is contributing to the escalating demand for prescription analgesics to experience chronic pain conditions, requiring specialized pain management that often involves prescription medications is propelling the market growth.

Breakup by Drug Class:

Opioids

NSAID

Others

Opioids hold the largest share of the market

A detailed breakup and analysis of the market based on the drug class has also been provided in the report. This includes opioids, NSAID, and others. According to the report, opioids accounted for the largest market share.

Opioids are a class of potent pain-relieving medications that act on the body's opioid receptors, providing effective relief from moderate to severe pain. In addition, opioids are employed to manage pain and are effective for severe pain, such as that experienced post-surgery, during cancer treatment, or in cases of chronic pain conditions, influencing the market growth. This effectiveness has made opioids a preferred choice for healthcare professionals and patients seeking relief from intense pain.

Moreover, opioids are used in pain management, with some formulations dating back centuries. While concerns about addiction and misuse exist, proper medical supervision and stringent prescription regulations helped curb these risks.

Additionally, the development of extended-release formulations that provide prolonged pain relief expanded the range of conditions for which opioids can be prescribed safely and effectively, thus augmenting the market growth.

Furthermore, the prevalence of chronic pain conditions, such as osteoarthritis and lower back pain is escalating the demand for opioids due to the growing geriatric population and as the burden of chronic pain, which is propelling the market growth.

Breakup by Route of Administration:

Oral

Parenteral

Topical

Transdermal

Rectal

Oral presently accounts for the largest market share

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes oral, parenteral, topical, transdermal, and rectal. According to the report, oral accounted for the largest market share.

The oral route of administration established itself as the dominant choice in the global market. In addition, the increasing use of oral analgesics offers convenience and ease of use that are available in various forms, including tablets, capsules, and liquids, making them accessible to numerous patients, and influencing the market growth. This versatility in dosage forms allows healthcare providers to tailor pain relief regimens to individual patient needs, enhancing patient compliance.

Moreover, oral medications are familiar among healthcare professionals and patients employed for numerous health conditions which fosters trust and confidence in the effectiveness of these medications, representing another major growth-inducing factor.

Besides this, the oral route provides a reliable and consistent absorption profile with a predictable absorption pattern, and ensures consistent pain relief for patients, accelerating the market growth.

Furthermore, the wide range of oral medications available, from over-the-counter (OTC) products to prescription medications, cater to various pain management needs are propelling the market growth.

Breakup by Pain Type:

Musculoskeletal

Surgical and Trauma

Cancer

Neuropathic

Migraine

Obstetrical

Fibromyalgia

Pain due to Burns

Dental/Facial

Pediatric

Others

Musculoskeletal pain dominates the market

A detailed breakup and analysis of the market based on the pain type has also been provided in the report. This includes musculoskeletal, surgical and trauma, cancer, neuropathic, migraine, obstetrical, fibromyalgia, pain due to burns, dental/facial, pediatric, and others. According to the report, musculoskeletal pain accounted for the largest market share.

Musculoskeletal pain includes numerous conditions affecting the muscles, bones, tendons, ligaments, and joints. It includes ailments such as osteoarthritis, rheumatoid arthritis, back pain, and sports-related injuries, among others.

Besides this, the growing geriatric population is susceptible to musculoskeletal pain due to the natural degeneration of joints and tissues. This shift led to a substantial increase in the prevalence of conditions including osteoarthritis, which often requires pain management solutions.

Apart from this, sedentary lifestyles, lack of physical activity, and poor ergonomics in work environments contribute to musculoskeletal issues. Individuals working long hours at desks or engaging in repetitive tasks are more susceptible to conditions including chronic back pain and carpal tunnel syndrome, driving the demand for medications.

Breakup by Application:

Internal

External

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes internal and external.

Internal application of analgesics involves the ingestion or injection of pain-relief medications which includes oral tablets, capsules, liquids, and injectable forms. It is developed to provide systemic relief by acting on the central nervous system, making it suitable for various pain types, including headaches, post-surgical pain, and systemic conditions.

External application of analgesics involves the use of topical formulations, such as creams, gels, patches, and ointments, applied directly to the skin at the site of pain. These products are designed to provide localized relief, making them particularly effective for musculoskeletal pain, joint pain, and surface injuries. It is gaining traction in the market due to its non-invasive nature, reduced risk of systemic side effects, and ease of use. Additionally, they are preferred by individuals seeking targeted pain relief without affecting the entire body.

Breakup by Region:

Asia Pacific

North America

Europe

Middle East and Africa

Latin America

North America leads the market, accounting for the majority of the analgesics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America market is driven by the growing healthcare infrastructure and rising healthcare expenditure. The United States boasts advanced medical facilities, a well-established pharmaceutical industry, and a strong emphasis on pain management to create a conducive environment for the development, manufacturing, and distribution of analgesic products.

Additionally, the prevalence of chronic pain conditions in the region is augmenting the market growth. Also, chronic pain affects millions of individuals across North America, with ailments including chronic lower back pain, osteoarthritis, and neuropathic pain being common which requires a consistent demand for medications and treatments, thus propelling the market growth.

Furthermore, the proactive approach to pain management and the promotion of pain relief options contribute to market domination. Healthcare professionals in the region are actively advocating for patient access to pain relief, and this awareness is further escalating the demand for medications.

Competitive Landscape:

At present, key players in the market are implementing various strategies to strengthen their positions and stay competitive in this dynamic industry. These strategies are driven by the need to address evolving consumer preferences, regulatory changes, and market trends. They are allocating substantial resources to research and develop (R&D) new drugs and formulations that offer improved pain relief, reduce side effects, and enhance patient compliance. It also focuses on exploring non-opioid alternatives to address concerns about opioid addiction and misuse. Moreover, companies are expanding their product portfolios by acquiring or partnering with smaller firms specializing in complementary pain management solutions which allows them to offer a wider range of medications, including over-the-counter (OTC) and prescription medications, topical creams, and medical devices. Besides this, key players are helping companies establish a strong presence in the market by collaborating with healthcare professionals to educate patients and providers about the benefits of their products.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Bayer AG

Novartis International AG

GlaxoSmithKline PLC

Pfizer Inc.

Johnson & Johnson Pvt. Ltd.

Reckitt Benckiser (RB) Group PLC

Endo Pharmaceuticals PLC

Bristol-Myers Squibb Company

Eli Lilly and Company

Sanofi SA

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In January 2021, Pfizer collaborated with Premier, an American healthcare improvement company that would offer five essential medications to healthcare practitioners to help them fulfill the long-term and immediate demands for medications essential to numerous patient care interventions.

In March 2020, Eli Lilly and Company teamed up with Pfizer, an American multinational pharmaceutical and biotechnology corporation to increase their efforts for the US FDA approval for a Biologics License Application for its tanezumab 2.5 administered subcutaneously for patients with chronic pain.

Key Questions Answered in This Report

• 1. What was the size of the global analgesics market in 2023?
• 2. What is the expected growth rate of the global analgesics market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global analgesics market?
• 4. What are the key factors driving the global analgesics market?
• 5. What is the breakup of the global analgesics market based on the type?
• 6. What is the breakup of the global analgesics market based on the drug class?
• 7. What is the breakup of the global analgesics market based on the route of administration?
• 8. What is the breakup of the global analgesics market based on the pain type?
• 9. What is the breakup of the global analgesics market based on the application?
• 10. What are the key regions in the global analgesics market?
• 11. Who are the key players/companies in the global analgesics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Analgesics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Type
• 5.5 Market Breakup by Drug Class
• 5.6 Market Breakup by Route of Administration
• 5.7 Market Breakup by Pain Type
• 5.8 Market Breakup by Application
• 5.9 Market Breakup by Region
• 5.10 Market Forecast

6 Market Breakup by Type

• 6.1 Prescription
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Over the counter (OTC)
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Drug Class

• 7.1 Opioids
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 NSAID
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

• 8.1 Oral
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Parenteral
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Topical
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Transdermal
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Rectal
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Pain Type

• 9.1 Musculoskeletal
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Surgical and Trauma
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Cancer
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Neuropathic
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Migraine
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast
• 9.6 Obstetrical
  • 9.6.1 Market Trends
  • 9.6.2 Market Forecast
• 9.7 Fibromyalgia
  • 9.7.1 Market Trends
  • 9.7.2 Market Forecast
• 9.8 Pain due to Burns
  • 9.8.1 Market Trends
  • 9.8.2 Market Forecast
• 9.9 Dental/Facial
  • 9.9.1 Market Trends
  • 9.9.2 Market Forecast
• 9.10 Pediatric
  • 9.10.1 Market Trends
  • 9.10.2 Market Forecast
• 9.11 Others
  • 9.11.1 Market Trends
  • 9.11.2 Market Forecast

10 Market Breakup by Application

• 10.1 Internal
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 External
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 Market Trends
  • 11.1.2 Market Forecast
• 11.2 Europe
  • 11.2.1 Market Trends
  • 11.2.2 Market Forecast
• 11.3 Asia Pacific
  • 11.3.1 Market Trends
  • 11.3.2 Market Forecast
• 11.4 Middle East and Africa
  • 11.4.1 Market Trends
  • 11.4.2 Market Forecast
• 11.5 Latin America
  • 11.5.1 Market Trends
  • 11.5.2 Market Forecast

12 Global Analgesics Industry: SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Global Analgesics Industry: Value Chain Analysis

• 13.1 Overview
• 13.2 Research and Development
• 13.3 Raw Material Procurement
• 13.4 Manufacturing
• 13.5 Marketing
• 13.6 Distribution
• 13.7 End-Use

14 Global Analgesics Industry: Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Global Analgesics Industry: Price Analysis

• 15.1 Price Indicators
• 15.2 Price Structure
• 15.3 Margin Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 Bayer AG
  • 16.3.2 Novartis International AG
  • 16.3.3 GlaxoSmithKline PLC
  • 16.3.4 Pfizer Inc.
  • 16.3.5 Johnson & Johnson Pvt. Ltd.
  • 16.3.6 Reckitt Benckiser (RB) Group PLC
  • 16.3.7 Endo Pharmaceuticals PLC
  • 16.3.8 Bristol-Myers Squibb Company
  • 16.3.9 Eli Lilly and Company
  • 16.3.10 Sanofi SA

List of Figures

• Figure 1: Global: Analgesics Market: Major Drivers and Challenges
• Figure 2: Global: Analgesics Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Analgesics Market: Breakup by Type (in %), 2023
• Figure 4: Global: Analgesics Market: Breakup by Drug Class (in %), 2023
• Figure 5: Global: Analgesics Market: Breakup by Route of Administration (in %), 2023
• Figure 6: Global: Analgesics Market: Breakup by Pain Type (in %), 2023
• Figure 7: Global: Analgesics Market: Breakup by Application (in %), 2023
• Figure 8: Global: Analgesics Market: Breakup by Region (in %), 2023
• Figure 9: Global: Analgesics Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 10: Global: Analgesics Industry: SWOT Analysis
• Figure 11: Global: Analgesics Industry: Value Chain Analysis
• Figure 12: Global: Analgesics Industry: Porter's Five Forces Analysis
• Figure 13: Global: Analgesics (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Analgesics (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Analgesics (Over the counter-OTC) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Analgesics (Over the counter-OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Analgesics (Opioids) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Analgesics (Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Analgesics (NSAID) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Analgesics (NSAID) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Analgesics (Others) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Analgesics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Analgesics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Analgesics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Analgesics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Analgesics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Analgesics (Topical) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Analgesics (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Analgesics (Transdermal) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Global: Analgesics (Transdermal) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Global: Analgesics (Rectal) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Global: Analgesics (Rectal) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Global: Analgesics (Musculoskeletal) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Global: Analgesics (Musculoskeletal) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: Global: Analgesics (Surgical and Trauma) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: Global: Analgesics (Surgical and Trauma) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: Global: Analgesics (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: Global: Analgesics (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Global: Analgesics (Neuropathic) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Global: Analgesics (Neuropathic) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Global: Analgesics (Migraine) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Global: Analgesics (Migraine) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Global: Analgesics (Obstetrical) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: Global: Analgesics (Obstetrical) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: Global: Analgesics (Fibromyalgia) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: Global: Analgesics (Fibromyalgia) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: Global: Analgesics (Pain due to Burns) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: Global: Analgesics (Pain due to Burns) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: Global: Analgesics (Dental/Facial) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: Global: Analgesics (Dental/Facial) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: Global: Analgesics (Pediatric) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: Global: Analgesics (Pediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Global: Analgesics (Other Pain Types) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Global: Analgesics (Other Pain Types) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Global: Analgesics (Internal) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Global: Analgesics (Internal) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: Global: Analgesics (External) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: Global: Analgesics (External) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: North America: Analgesics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: North America: Analgesics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: Europe: Analgesics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: Europe: Analgesics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: Asia Pacific: Analgesics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: Asia Pacific: Analgesics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: Middle East and Africa: Analgesics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: Middle East and Africa: Analgesics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 67: Latin America: Analgesics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 68: Latin America: Analgesics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

• Table 1: Global: Analgesics Market: Key Industry Highlights, 2023 & 2032
• Table 2: Global: Analgesics Market Forecast: Breakup by Type (in Million US$), 2024-2032
• Table 3: Global: Analgesics Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
• Table 4: Global: Analgesics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
• Table 5: Global: Analgesics Market Forecast: Breakup by Pain Type (in Million US$), 2024-2032
• Table 6: Global: Analgesics Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 7: Global: Analgesics Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 8: Global: Analgesics Market Structure
• Table 9: Global: Analgesics Market: Key Players